np_gilmore
TL3 Nurse practitioner · Perth, AU
Nurse practitioner in a metabolic clinic. Injection technique, site rotation, and the practical side of adherence.
Joined 22 January 2025 · last posted 6h · groups: clinicians, wiki-editors
134Posts here
6Topics
1Solutions
896Likes received
986Likes given
31Badges
125Days visited
2.9kPosts read
Stated areas
Recent activity
Full stream-
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Replied, post #3 · Devices › Pens & autoinjectors · 28 Jul 2026 · 3 likes Coming back to the opening post, because the follow-up matters more than the original answer. Visibility of the dose: some pens allow you to see the insulin remaining;…
-
Follow-up: Reading an interaction checker output critically Replied, post #52 · Practice › Interactions · 18 Jul 2026 · 0 likes Coming back to post #50, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #8 · Clinical › Prescriber conversations · 17 Jul 2026 · 12 likes post #7 is right about the mechanism and I think understates the practical bit. Questions about dose: asking "how will we determine whether this dose is working for me"…
-
What is genuinely unknown about long-term amylin agonism Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #5 · Clinical › Bloodwork · 15 Jul 2026 · 2 likes I read post #3 twice before replying, because I had assumed the opposite. A single value outside interval: usually uninformative on a single draw. What makes a result…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #71 · Analytics › Home & field testing · 12 Jul 2026 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #44 · Clinical › Comorbidities · 12 Jul 2026 · 12 likes Worth separating two things that post #40 runs together. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without…
-
Reading a home test result without over-claiming Replied, post #109 · Analytics › Home & field testing · 7 Jul 2026 · 4 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #28 · Practice › Side effects · 3 Jul 2026 · 7 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #109 · Evidence › Journal club · 3 Jul 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #63 · Analytics › Impurities & related substances · 1 Jul 2026 · 3 likes This follows post #60 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Sulfonylureas: the interaction most worth taking seriously — what changed since Replied, post #4 · Practice › Interactions · 1 Jul 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
Maintains 4 documents
- Survodutide — referenceReview due 20 Jan 2027
- Growth-hormone-releasing peptides (GHRP class) — referenceReview due 14 Mar 2027
- Ipamorelin — referenceReview due 13 Mar 2027
- STEP 3 — trial digestReview due 27 Jan 2027